title: Reversed-phase high-performance liquid chromatography combined with tandem mass spectrometry in studies of a substance P-converting enzyme from human cerebrospinal fluid.
abstract: The application of reversed-phase HPLC in combination with micro-electrospray mass spectrometry to study a substance P (SP)-hydrolysing endoprotease in human cerebrospinal fluid (hCSF) is reported. The enzyme was partially purified from the hCSF specimens by ion-exchange chromatography and molecular sieving. During the purification procedure the enzyme activity was monitored by measuring the formation of the SP-fragment 1-7 from SP by radioimmunoassay. Regarding its behaviour upon molecular sieve chromatography, the enzyme was suggested to be associated with an apparent molecular mass of around 100 x 10(3). In subsequent experiments using the partially purified endopeptidase, the hydrolysis of SP was demonstrated by HPLC. The reaction product mixture was resolved in several components including the N-terminal fragments 1-8, 1-7 and 1-6 and the C-terminal fragment 8-11. The identity of these fragments were confirmed by tandem mass spectrometry. It was concluded that the present SP-degrading enzyme is different from those previously identified and purified from hCSF. The applied techniques were proven to be highly efficient for the recovery and identification of the released peptide products.
authors.affiliation: Department of Pharmaceutical Biosciences, Uppsala University, Sweden.
authors.forename: U
authors.initials: U
authors.lastname: Eriksson
authors.forename: P E
authors.initials: PE
authors.lastname: Andrén
authors.forename: R M
authors.initials: RM
authors.lastname: Caprioli
authors.forename: F
authors.initials: F
authors.lastname: Nyberg
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism; D002216:Captopril / Q000378:metabolism; D002847:Chromatography, Agarose; D002850:Chromatography, Gel; D002851:Chromatography, High Pressure Liquid; D003217:Conductometry; D003429:Cross Reactions / Q000276:immunology; D010450:Endopeptidases / Q000134:cerebrospinal fluid* / Q000302:isolation & purification / Q000378:metabolism; D008401:Gas Chromatography-Mass Spectrometry; D006020:Glycopeptides / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D007106:Immune Sera / Q000276:immunology; D007457:Iodine Radioisotopes; D010446:Peptide Fragments / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D010455:Peptides; D011480:Protease Inhibitors / Q000378:metabolism; D011817:Rabbits; D011863:Radioimmunoassay; D013056:Spectrophotometry, Ultraviolet; D013373:Substance P / Q000378:metabolism*
chemical_list: D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D007106:Immune Sera; D007457:Iodine Radioisotopes; D010446:Peptide Fragments; D010455:Peptides; D011480:Protease Inhibitors; D013373:Substance P; C016977:amastatin; D002216:Captopril; D010450:Endopeptidases; C008890:phosphoramidon